Biopharmaceutical company
H.J. Res. 59, Bipartisan Budget Act of 2013 as it relates to Medicare reimbursement. Issues concerning incenting antibiotic development. H.R. 3204, The Drug Quality and Security Act and S. 959, The Pharmaceutical Quality, Security and Accountability Act as they relate to the tracking and tracing of pharmaceutical drugs; issues related to antibiotics and breakpoints. Issues related to Medicare reimbursement for new technologies.
BUD - Budget/Appropriations HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
MARY BETH SAVARY TAYLOR STACEY HUGHES EMILY PORTER STACEY HUGHES MARY BETH SAVARY TAYLOR EMILY PORTER MARY BETH SAVARY TAYLOR STACEY HUGHES EMILY PORTER